1. Makuuchi H, Shimada H, Chino S, Tanaka H, Nishi T, Kise T. Endoscopic mucosal resection for m3/sm1 esophagus cancer. Clin Gastroenterol. 2003;18:1487–92.
2. Shimada H, Makuuchi H, Chino O, Nishi T, Kise Y, Hanashi T, Kenmochi T, Yamamoto S, Hara T, Kato Y. Clinical outcome of surgical treatment for m3/sm esophageal cancer-A point of view on three-field lymph node dissection. Stomach Intest (Tokyo). 2002;37:1273–84.
3. The April 2007 edition of the Japanese Guidelines for Diagnosis and Treatment of Esophageal Cancers.
4. Momma K, Yoshida M, Fujiwara J, Egashira H, Kuruma S, Egawa N, et al. A study in the indication for additional treatment after EMR on T1a-MM and SM1 esophageal cancer. Stomach Intest (Tokyo). 2007;42:1341–54.
5. Font A, Arellano A, Fernandez-Llamazares J, et al. Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancer. Clin Transl Oncol. 2007;9(3):177–82.